Digestive Diseases and Sciences

, Volume 51, Issue 10, pp 1744–1748

Nocturnal Hydration—An Effective Modality to Reduce Recurrent Abdominal Pain and Recurrent Pancreatitis in Patients with Adult-Onset Cystic Fibrosis

  • Kamil Obideen
  • Mohammad Wehbi
  • Maarouf Hoteit
  • Qiang Cai
Original Article
  • 67 Downloads

Abstract

Recurrent abdominal pain and recurrent pancreatitis are common problems associated with some patients with cystic fibrosis (CF). There is no known effective method to prevent recurrent abdominal pain and recurrent pancreatitis in such patients. The objective of this study was to determine whether nocturnal hydration (NH) prevents recurrent abdominal pain and recurrent acute pancreatitis in patients with adult-onset CF. Adult CF patients who were referred to our Pancreatic Diseases Clinic for recurrent abdominal pain and pancreatitis were enrolled in the study. Each patient was encouraged to drink plenty of water during the night and established a 6-month diary (3 months before and 3 months after NH was initiated), recording the frequency and severity of their abdominal pain, the amount of pain medication taken, and the volume of their water intake. We also reviewed the number of doctor's clinic visits, emergency room visits, and hospitalizations for about 1 year before and 1 year after the initiation of the NH. The frequency and the severity of abdominal pain in this group of patients were significantly reduced. The amount of pain medication and the number of emergency room visits and hospitalizations for abdominal pain and acute pancreatitis were reduced. NH is a simple and cost-effective method to prevent recurrent abdominal pain and pancreatitis in patients with adult-onset CF.

Keywords

Nocturnal hydration Cystic fibrosis Recurrent pancreatitis. 

References

  1. 1.
    Ratjen F, Doring G (2003) Cystic fibrosis. Lancet 361:681–689PubMedCrossRefGoogle Scholar
  2. 2.
    Witt DR, Schaefer C, Hallam P, Wi S, Blumberg B, Fishbach A, Holtzman J, Kornfeld S, Lee R, Nemzer L, Palmer R (1996) Cystic fibrosis heterozygote screening in 5,161 pregnant women. Am J Hum Genet 58:823–835PubMedGoogle Scholar
  3. 3.
    Rommens JM, Iannuzzi MC, Kerem B, Drumm ML, Melmer G, Dean M, Rozmahel R, Cole JL, Kennedy D, Hidaka N (1989) Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245:1059–1065PubMedCrossRefGoogle Scholar
  4. 4.
    Liddle RA, Cohn JA (1995) Hereditary diseases of the pancreas. In: Yamada T, et al. (eds) Textbook of gastroenterology, 2nd edn. Lippincott Williams & Wlikins, Philadelphia, PA, pp 2161– 2173Google Scholar
  5. 5.
    Rosner B (2000) Fundamentals of biostatistics, 5th edn. Duxbury Press, Pacific Grove, CAGoogle Scholar
  6. 6.
    Rowntree RK, Harris A (2003) The phenotypic consequences of CFTR mutations. Ann Hum Genet 67:471–485PubMedCrossRefGoogle Scholar
  7. 7.
    Groman JD, Meyer ME, Wilmott RW, Zeitlin PL, Cutting GR (2002) Variant cystic fibrosis 7. phenotypes in the absence of CFTR mutations. N Engl J Med 347:401–407PubMedCrossRefGoogle Scholar
  8. 8.
    Cohn JA, Friedman KJ, Noone PG, Knowles MR, Silverman LM, Jowell PS (1998) Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med 339:653–658PubMedCrossRefGoogle Scholar
  9. 9.
    Sharer N, Schwarz M, Malone G, Howarth A, Painter J, Super M, Braganza J (1998) Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 339:645–652PubMedCrossRefGoogle Scholar
  10. 10.
    Lyon E, Miller C (2003) Current challenges in cystic fibrosis screening. Arch Pathol Lab Med 127:1133–1139PubMedGoogle Scholar
  11. 11.
    Kerem E, Kerem B (1996) Genotype-phenotype correlations in cystic fibrosis. Pediatr Pulmonol 22:387–395PubMedCrossRefGoogle Scholar
  12. 12.
    Zielenski J (2000) Genetype and phenotype in cystic fibrosis. Respiration 67:117–133PubMedCrossRefGoogle Scholar
  13. 13.
    Durno C, Corey M, Zielenski J, Tullis E, Tsui LC, Durie P (2002) Genotype and phenotype. Gastroenterology 123:1857–1864PubMedCrossRefGoogle Scholar
  14. 14.
    Taylor CJ, Aswani N (2002) The pancreas in cystic fibrosis. Pediatr Respir Rev 3:77–81CrossRefGoogle Scholar
  15. 15.
    Shwachman H, Lebenthal E, Khaw KT (1975) Recurrent acute pancreatitis in patients with cystic fibrosis with normal pancreatic enzymes. Pediatrics 55:86PubMedGoogle Scholar
  16. 16.
    Gilljam M, Ellis L, Corey M, Zielenski J, Durie P, Tullis DE (2004) Clinical manifestations of cystic fibrosis among patients with diagnosis in adulthood. Chest 126:1215–1224PubMedCrossRefGoogle Scholar
  17. 17.
    Zeitlin P (2003) Emerging drug treatment for cystic fibrosis. Expert Opin Emerg Drugs 8:523–535PubMedCrossRefGoogle Scholar
  18. 18.
    Choudari CP, Imperiale TF, Sherman S, Fogel E, Lehman GA (2004) Risk of pancreatitis with mutation of CF gene. Am J Gastroenterol 99:1358–1363PubMedCrossRefGoogle Scholar
  19. 19.
    Ockenga J, Stuhrmann M, Ballmann M, Teich N, Keim V, Dork T, Manns MP (2000) Mutations of CF gene, not cationic trypsinogen gene, are associated with recurrent or chronic idiopathic pancreatitis. Am J Gastroenterol 95:2061–2067PubMedCrossRefGoogle Scholar
  20. 20.
    Noone PG, Zhou Z, Silverman LM, Jowell PS, Knowles MR, Cohen JA (2001) CF gene mutations and pancreatitis risk: relation to epithelial ion transport and trypsin inhibitor gene mutations. Gastroenterology 121:1310–1319PubMedCrossRefGoogle Scholar
  21. 21.
    Pezzilli R, Morselli-Labate AM, Mantovani V, Romboli E, Selva P, Migliori M, Corinaldesi R, Gullo L (2003) Mutations of CFTR gene in pancreatic disease. Pancreas 27:332–336PubMedCrossRefGoogle Scholar
  22. 22.
    Frulloni L, Castellani C, Bovo P, Vaona B, Calore B, Liani C, Mastella G, Cavalliani G (2003) Natural history of pancreatitis associated with cystic fibrosis gene mutations. Dig Liver Dis 35:179–185PubMedCrossRefGoogle Scholar
  23. 23.
    Durno C, Corey M, Zielenski J, Tullis E, Tsui LC, Durie P (2002) Genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis. Gastroenterology 123:1857–1864PubMedCrossRefGoogle Scholar
  24. 24.
    Gelrud A, Sheth S, Banerjee S, Weed D, Shea J, Chuttani R, Howell DA, Telford JJ, Carr-Locke DL, Regan MM, Ellis L, Durie PR, Freedman SD (2004) Analysis of cystic fibrosis gene product (CFTR) function in patients with pancreatic divisum and recurrent acute pancreatitis. Am J Gastroenterol 99:1557–1562PubMedCrossRefGoogle Scholar
  25. 25.
    Kopelman H, Forstner G, Durie P, Corey M (1989) Origins of chloride and bicarbonate secretory defects in the cystic fibrosis pancreas, as suggested by pancreatic function studies on control and CF subjects with preserved pancreatic function. Clin Invest Med 12:207–211PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2006

Authors and Affiliations

  • Kamil Obideen
    • 1
  • Mohammad Wehbi
    • 1
  • Maarouf Hoteit
    • 1
  • Qiang Cai
    • 1
  1. 1.Division of Digestive DiseasesEmory University School of MedicineAtlantaUSA

Personalised recommendations